Bacterial Infections
📧 Sign up to get email alerts when something new happens for Bacterial Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-12-31Clinical Trial Update: Early Versus Expectant Treatment of Ureaplasma Infection in Very Low Birth Weight Neonates [Phase 1, Phase 2]
This clinical trial update reports results from a Phase 1/2 study comparing early treatment versus expectant management of Ureaplasma infect…
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult Subjects [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of intravenous RPX2003 (biapenem) in healthy adult subjects; the trial h…
-
CLINICAL_TRIALS trial_result · 2012-10-24Clinical Trial Update: Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age [Phase 2]
Phase 2 pediatric study evaluating the pharmacokinetics, safety, and tolerability of tigecycline in children aged 8 to 11 years has complete…
-
FDA approval · 2012-05-31FDA Approved: CLINDAMYCIN IN 5 PERCENT DEXTROSE — Original Application (Sandoz Inc)
The FDA approved an Original Application for a generic clindamycin in 5% dextrose injection by Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2012-05-01Clinical Trial Update: Zithromax-SR 2g, Special Investigation (Regulatory Post Marketing Commitment Plan)
Clinical trial update for Zithromax-SR 2g under a regulatory post-marketing commitment shows the study is completed with results posted in 2…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: Amoxicillin Bioequivalence Study Brazil - Fast [Phase 1]
Phase 1 bioequivalence study of amoxicillin in Brazil has completed, with results posted on 2012-02-07.
-
FDA approval · 2011-09-30FDA Approved: CLINDAMYCIN — Original Application (Sagent Pharmaceuticals)
FDA approved Sagent Pharmaceuticals' original application for CLINDAMYCIN PHOSPHATE (clindamycin), a generic antibiotic for treating suscept…
-
CLINICAL_TRIALS trial_result · 2011-07-26Clinical Trial Update: Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy Volunteers [Phase 4]
Phase 4 trial comparing ophthalmic azithromycin (AzaSite) with moxifloxacin (Vigamox) in healthy volunteers has completed and results were p…
-
CLINICAL_TRIALS trial_result · 2011-04-26Clinical Trial Update: Relative Bioavailability Study Of Two Lincomycin Hydrochloride Hard Gelatinous Capsule [Phase 1]
Pfizer conducted a Phase 1 relative bioavailability study comparing two lincomycin hydrochloride hard gelatin capsules. The study status is …
-
CLINICAL_TRIALS trial_result · 2011-04-15Clinical Trial Update: Study Evaluation Tazocin Intervention [Phase 4]
A Phase 4 trial evaluating Tazocin for bacterial infections has completed; Wyeth is now a wholly owned subsidiary of Pfizer.
-
CLINICAL_TRIALS trial_result · 2011-01-05Clinical Trial Update: What is the Prevalence of Methicillin-Resistant Staphylococcus Aureus in Skin and Soft Tissue Infections Presenting to the Emergency Departments of a Canadian Academic Health Care Center?
This completed clinical trial reports the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in skin and soft tissue infection…
-
CLINICAL_TRIALS trial_result · 2010-08-20Clinical Trial Update: Retapamulin Ointment in Healthy Adults Nasally Colonized With Staphylococcus Aureus [Phase 2]
Phase 2 clinical trial evaluating retapamulin ointment for nasal decolonization of Staphylococcus aureus in healthy adults; results have bee…
-
CLINICAL_TRIALS trial_result · 2010-07-09Clinical Trial Update: The Rate of C-reactive Protein (CRP) Increase as a Marker for Bacterial Infections in Children
A clinical trial update examining the rate of C-reactive protein (CRP) increase as a potential marker of bacterial infections in children.
-
CLINICAL_TRIALS trial_result · 2010-03-18Clinical Trial Update: Reducing Vaginal Infections in Women [Phase 3]
A Phase 3 clinical trial evaluating strategies to reduce vaginal infections in women has completed.
-
CLINICAL_TRIALS research · 2010-02-24Clinical Trial Update: Human Innate Immune Responses To Mycobacterial Aerodigestive Tract Infection [NA]
A clinical trial investigating human innate immune responses to mycobacterial aerodigestive tract infection has completed.
-
EMA withdrawal · 2010-01-11EMA Withdrawn: Turvel (trovafloxacin) — Pfizer Limited
EMA has withdrawn Turvel (trovafloxacin) from the market for bacterial infections after a decision by Pfizer Limited.
-
EMA withdrawal · 2009-12-31EMA Withdrawn: Trovan (trovafloxacin) — Pfizer Limited
The European Medicines Agency has withdrawn Trovan (trovafloxacin) from the market; the decision affects its use for bacterial infections.
-
EMA withdrawal · 2009-12-31EMA Withdrawn: Trovan IV (alatrofloxacin mesilate) — Pfizer Limited
EU status: Trovan IV (alatrofloxacin mesilate) withdrawn from the market by Pfizer Limited as of 31/12/2009.
-
CLINICAL_TRIALS trial_result · 2009-10-27Clinical Trial Update: Ciprofloxacin on Burned Patients [Phase 3]
A Bayer-sponsored Phase 3 trial evaluating ciprofloxacin for bacterial infections in burn patients has completed.
-
CLINICAL_TRIALS trial_result · 2009-09-21Clinical Trial Update: Antiseptic Use and Dressing Application [Phase 4]
Phase 4 clinical trial update on antiseptic use and dressing application aimed at reducing skin colonization and catheter-related infection.
-
FDA approval · 2009-08-26FDA Approved: CLINDAMYCIN HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for Clindamycin Hydrochloride from Aurobindo Pharma Limited, adding a generic clindamycin HCl product …
-
CLINICAL_TRIALS trial_result · 2008-10-17Clinical Trial Update: Safety of a Single Dose of 5 mg of hLF1-11 Given to Autologous Haematopoietic Stem Cell Transplant Recipients [Phase 1, Phase 2]
Phase 1/2 trial update evaluating the safety of a single 5 mg dose of hLF1-11 in autologous hematopoietic stem cell transplant recipients.
-
CLINICAL_TRIALS trial_result · 2008-06-10Clinical Trial Update: Leukocyte Depletion of Autologous Whole Blood [Phase 4]
This Phase 4 trial evaluating leukocyte depletion of autologous whole blood in patients with bacterial infections and sepsis has completed.
-
CLINICAL_TRIALS trial_result · 2008-01-15Clinical Trial Update: Unfractioned Heparin for Treatment of Sepsis [Phase 3]
A Phase 3 clinical trial evaluating unfractionated heparin for the treatment of sepsis has completed. Sponsored by Universidad de Antioquia,…
-
EMA safety_alert · 2007-03-30European Medicines Agency recommends restricted use and strengthened warnings for Ketek
EMA recommends restricted use and stronger warnings for Ketek (telithromycin) due to safety concerns, limiting indications and enhancing ris…